Predictors of breast and cervical cancer screening in a Spanish metropolitan area

Journal of Women's Health

Volumn 19, Issue 9, 2010, Pages 1675-1681

  López De Andrés, Ana ^a   Martin Lopez, Rocio ^a   Hernández Barrera, Valentín ^a   Carrasco Garrido, Pilar ^a   Gil De Miguel, Ángel ^a   Esteban Y Peña, Maria Mercedes ^b   Jiménez García, Rodrigo ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Institute de Salud Pública Madrid Salud   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CHRONIC DISEASE; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBESITY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SPAIN; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; SPAIN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77956364008     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1828     Document Type: Article

References (51)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
2. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-686.
3. Boyle P, Autier P, Bartelink H, et al. European code against cancer and scientific justification: Third version (2003). Ann Oncol 2003;14:973-1005.
4. CTFPHC systematic reviews and recommendations, 2004, Canada. Available at http://www.ctfphc.org/Accessed April 14, 2009.
5. Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Ca-samitjana M. Descripcion del cribado del cancer en Espafta. Proyecto DESCRIC. Madrid: Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Agencia d'Avaluacio de Tecnologia i Recerca Mediques de Cataluna; 2007. Informes de Evaluacion de Tecnologias Sa-nitarias, AATRM num. 2006/01.
6. Screening for cervical cancer. What's new from the USPSTF? AHRQ Publication No. APPIP03-0004. Rockville, MD: Agency for Healthcare Research and Quality, 2003.
7. Fletcher SW. Screening average risk women for breast cancer. Update 2007. Available at www.uptodate.com/Accessed April 14, 2009.
8. Marzo Castillejo M, Bellas Beceiro B, Nuin Villanueva M, Cierco Peguera P, Moreno Baquerano M. Estrategias de prevencion del cancer. Aten Primaria 2007;39:47-66.
9. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;(4): CD001877 2006.
10. Esteva M, Ripoll J, Leiva A, Sanchez-Contador C, Collado F. Determinants of nonattendance to mammography program in a region with high voluntary health insurance coverage. BMC Public Health 2008;8:387.
11. Bare ML, Montes J, Florensa R, Sentis M, Donoso L. Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 2003;12: 487-494.
12. Luengo-Matos S, Polo-Santos M, Saz-Parkinson Z. Mam-mography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. Eur J Cancer Prev 2006;15:242-248.
13. Cabeza E, Esteva M, Pujol A, Thomas V, Sanchez-Contador C. Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev 2007;16:372-379.
14. Luengo Matos S, Muftoz van den Eynde A. Use of Pap smear for cervical cancer screening and factors related to its use in Spain. Aten Primaria 2004;33:229-234.
15. Rohlfs I, Borrell C, Plasencia A, Pasarin I. Social inequalities and realisation of opportunistic screening mammographies in Barcelona (Spain). J Epidemiol Community Health 1998; 52:205-206.
16. Puig-Tintore LM, Castellsague X, Torne A, et al. Coverage and factors associated with cervical cancer screening: Results from the AFRODITA study: A population-based survey in Spain. J Low Genit Tract Dis 2008;12:82-89.
17. von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Sociodemographic determinants of participation in mammography screening. Int J Cancer 2008;122:418-423.
18. Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: What are the linkages to chronic disease risk? Prev Chronic Dis 2004;1:A04.
19. Coughlin SS, Leadbetter S, Richards T, Sabatino S. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med 2008;66:260-275.
20. Anttila A, von Karsa L, Aasmaa A, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009;45:2649-2658.
21. Galan I, Rodriguez-Artalejo F, Diez-GaMn L, Tobias A, Zorrilla B, Gandarillas A. Clustering of behavioural risk factors and compliance with clinical preventive recommendations in Spain. Prev Med 2006;42:343-347.
22. Jimeinez-Garcia R, Hernaindez-Barrera V, Carrasco-Garrido P, Lopez de Andres A, Esteban y Pena MM, Gil de Miguel A. Coverage and predictors of influenza vaccination among adults living in a large metropolitan area in Spain: A comparison between the immigrant and indigenous populations. Vaccine 2008;26:4218-4223.
23. Zhang P, Tao G, Irwin KL. Utilization of preventive medical services in the United States: A comparison between rural and urban populations. J Rural Health 2000;16:349-356.
24. Larson SL, Fleishman JA. Rural-urban differences in usual source of care and ambulatory service use: Analyses of national data using Urban Influence Codes. Med Care 2003;41: 65-74.
25. Carrasco-Garrido P, De Miguel AG, Barrera VH, Jimenez-Garcla R. Health profiles, lifestyles and use of health resources by the immigrant population resident in Spain. Eur J Public Health 2007;17:503-507.
26. Madrid City Council. Madrid City Health Survey (Encuesta de Salud de la ciudad de Madrid, ESCM05). Available at www.madridsalud.es/publicaciones/ encuesta-salud2005.pdf Accessed April 14, 2009.
27. Gobierno Hernandez J, Dominguez Coello S, Hernandez Diaz F, Fernandez Hernandez JA, Garcia Marrero MR, Diaz Gonzalez L. Opportune intervention of family doctors in the programme of early detection of breast cancer. Aten Pri-maria 2008;4:187-192.
28. Carrasquillo O, Pati S. The role of health insurance on Pap smear and mammography utilization by immigrants living in the United States. Prev Med 2004;3985:943-950.
29. De Alba, Hubbell FA, McMullin JM; Sweningson JM, Saitz R. Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med 2005;20:290-296.
30. Selvin E, Brett KM. Breast and cervical cancer screening: Sociodemographic predictors among white, black, and Hispanic women. Am J Public Health 2003;93:618-623.
31. Tatla RK, Paszat LF, Bondy SJ, Chen Z, Chiarelli AM, Mai V. Socioeconomic status and returning for a second screen in the Ontario breast screening program. Breast 2003;12:237-246.
32. Taylor R, Ivanov O, Page A, Brotherton J, Achat H, Close G. Predictors of non-attendance from BreastScreen NSW in women who report current mammography screening. Aust NZ J Public Health 2003;27:581-587.
33. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754-760.
34. Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in U.S. women. Am J Public Health 1993;83:53-60.
35. Bostick RM, Sprafka JM, Virnig BA, Potter JD. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med 1994;23:816-826.
36. Katz SJ, Zemencuk JK, Hofer TP. Breast cancer screening in the United States and Canada, 1994: Socioeconomic gradients persist. Am J Public Health 2000;90:799-803.
37. Kiefe C, Funkhouser E, Douad M, May D. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998;13:357-365.
38. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005;43:132-140.
39. Ferrane JM, Chen PH, Crabtree BF, Warternberg D. Cancer screening in women. Body mass index and adherence to physician recommendations. Am J Prev Med 2007;32:525-531.
40. Mitchell R, Padwal R, Chuck A, Klarenbach SW. Cancer screening among overweight and obese in Canada. Am J Prev Med 2008;35:127-132.
41. Rakowski W, Clark MA, Truchil R, Schneider K, Meersman S. Smoking status and mammography among women aged 50-75 in the 2002 Behavioral Risk Factor Surveillance System. Women Health 2005;41:1-21.
42. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a pro-spectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
43. Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Gil A. Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care 2009;32:1470-1472.
44. Pieta B, Samulak D, Opala T, et al. Women's lifestyle and the risk of breast tumors. Eur J Gynaecol Oncol 2009;30:186-189.
45. Thune I. Assessments of physical activity and cancer risk. Eur J Cancer Prev 2000;9:387-393.
46. Martin LM, Leff M, Calonge N, Garret C, Nelson DE. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000;18:215-218.
47. Palta M, Prineas RJ, Berman R, Hannan P. Comparison of self-reported and measured height and weight. Am J Epidemiol 1982;115:223-230.
48. Basterra Gortari FJ, Bes Rastrollo M, Forga Ll, Martinez JA, Martinez-Gonzalez MA. Validacion del indice de masa corporal auto-referido en la Encuesta Nacional de Salud. An Sist Sanit Navar 2007;30:373-381.
49. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-726.
50. U.S. Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002;137:344-346.
51. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-1256.